Related Experiment Video
Updated: Jun 22, 2026
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Anthracycline extravasation injuries: management with dexrazoxane
Karin Jordan1, Timo Behlendorf, Franziska Mueller
1Clinic for Internal Medicine IV, Department for Oncology and Haematology, University Hospital Halle, Halle, Germany.
Therapeutics and Clinical Risk Management
|June 19, 2009
Summary
Anthracycline extravasation can cause severe tissue damage. Dexrazoxane is the first and only proven antidote, effectively preventing necrosis and ulceration in clinical studies.
Area of Science:
- Oncology
- Pharmacology
- Dermatology
Background:
- Anthracyclines are vital anticancer drugs but carry a risk of extravasation injury.
- Extravasation can lead to severe complications like tissue necrosis and skin ulceration.
- Effective treatment for anthracycline extravasation has been lacking until recently.
Purpose of the Study:
- To review the development and clinical implementation of dexrazoxane.
- To highlight dexrazoxane as the first proven antidote for anthracycline extravasation.
- To discuss the management of dexrazoxane in extravasation injuries.
Main Methods:
- Review of preclinical and clinical studies on dexrazoxane efficacy.
- Analysis of multicenter study data on dexrazoxane in anthracycline extravasation.
- Focus on the therapeutic role and management strategies.
Main Results:
- Dexrazoxane has emerged as the first and only clinically proven antidote for anthracycline extravasation.
- Two multicenter studies demonstrated dexrazoxane's high efficacy in preventing skin necrosis and ulceration.
- Clinical implementation of dexrazoxane is supported by robust evidence.
Conclusions:
- Dexrazoxane represents a significant advancement in managing anthracycline extravasation injuries.
- It offers a crucial therapeutic option to mitigate the severe consequences of extravasation.
- Further understanding of its management will optimize patient outcomes.
Related Concept Videos
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...